NOTCH2 and acute lymphoblastic leukemia: Moreover, the miR-1246/1248-NOTCH2 may provide a clue for the relapse of pediatric T-ALL, and 5-fluorouracil/ascorbate/trastuzumab targeting miR-1246 may serve as potential candidates for the T-ALL.